Abstract
<i>In silico</i> and <i>in vitro</i> evaluation of kaempferol as a potential inhibitor of the <scp>SARS‐CoV</scp>‐2 main protease (<scp>3CLpro</scp>)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
